nybanner

        Products

        API-Drug Peptide Ziconotide/OMEGA-CGTX MVII A N-type calcium channel blocker

        Short Description:

        Ziconotide is an artificial synthesis of hydrophilic polypeptide ω-MVIIA in the venom peptide of Pacific fish-eating snail-chicken heart snail, and it is the first new non-opioid ?druganalgesic to be used in clinic. Ziconotide ?can be used as a non-opioid analgesic drug for intrathecal administration.?


        Product Detail

        Product Tags

        About This Item

        It is suitable for intrathecal injection and other treatment methods (such as systemic analgesics, adjuvant therapy or sheath) Ziconotide is a powerful, selective and reversible N-type voltage-sensitive calcium channel blocker, which is effective for refractory pain, and does not produce drug resistance after long-term administration, and it does not cause physical and mental dependence, nor does it cause life-threatening respiratory depression due to overdose. The recommended daily dose is less, with good curative effect, high safety, less adverse reactions, no drug resistance and addiction. This product has a huge market prospect as a painkiller.

        Product Dispaly

        IMG_20200609_154048
        IMG_20200609_155449
        IMG_20200609_161417

        Why Choose Us

        According to incomplete statistics, the incidence of pain in the world is about 35% ~ 45% at present, and the incidence of pain in the elderly is relatively high, about 75% ~ 90%. An American survey shows that the incidence of migraine increased from 23.6 million in 1989 to 28 million in 2001. In the investigation of chronic pain in six cities in China, it is found that the incidence of chronic pain in adults is 40%, and the rate of medical treatment is 35%; The incidence of chronic pain in the elderly is 65% ~ 80%, and the rate of seeing a doctor is 85%. In recent years, the medical expenses for pain relief are increasing year by year.
        From 2013 to July 2015, the Pain Research Center in the United States and several medical institutions conducted a long-term, multi-center and observational study on intrathecal injection of ziconotide in 93 adult white female patients with severe chronic pain. The pain digital score scale and the overall sensory score of patients with intrathecal injection of ziconotide and without injection of ziconotide were compared Among them, 51 patients used intrathecal injection of ziconotide, while 42 patients did not. The baseline pain scores were 7.4 and 7.9, respectively. The recommended dose of intrathecal injection of ziconotide was 0.5-2.4 mcg/ day, which was adjusted according to the patient's pain response and side effects. The average initial dose was 1.6 mcg/ day, 3.0 mcg/ day at 6 months and 2.5 at 9 months. At 12 months, it was 1.9 mcg/ day, and after 6 months, the decrease rate was 29.4%, the contrast increase rate was 6.4%, and the improvement rate of overall sensory score was 69.2% and 35.7% respectively. After 12 months, the decrease rate was 34.4% and 3.4% respectively, and the improvement rate of overall sensory score was 85.7% and 71.4% respectively. The highest side effects were nausea (19.6% and 7.1%), hallucination (9.8% and 11.9%) and dizziness (13.7% and 7.1%). The results of this study once again confirmed the effectiveness and safety of ziconotide recommended as a first-line intrathecal injection.

        The preliminary study on ziconotide can be traced back to the 1980s, when the potential therapeutic application of rigid and protein-like peptides in conus venom was explored for the first time. These conotoxins are small peptides rich in disulfide bonds, usually 10-40 residues in length, to target various ion channels, GPCR and transporter proteins efficiently and selectively. Ziconotide is a 25-peptide derived from Conus magus, which contains three disulfide bonds, and its short β-fold is spatially arranged into a unique three-dimensional structure, which allows it to selectively inhibit CaV2.2 channels.


      1. Previous:
      2. Next:

      3. 主站蜘蛛池模板: 97视频免费在线| 中文丰满岳乱妇在线观看| 狂野欧美性猛交xxxx巴西| 国产强伦姧在线观看| japanese日本熟妇多毛| 日韩在线观看一区二区三区| 亚洲网红精品大秀在线观看 | 97色精品视频在线观看| 无遮挡又黄又爽又色的动态图1000| 亚洲国产精品久久网午夜| 粗大的内捧猛烈进出在线视频| 国产免费一区二区三区在线观看| 2023天天操| 奇米影视7777狠狠狠狠色| 久久一区二区三区免费播放| 欧美69式视频在线播放试看| 伊人婷婷综合缴情亚洲五月| 脱裙打光屁股打红动态图| 国产成人高清亚洲一区91| 91精品福利一区二区| 婷婷啪啪婷婷啪啪| 久久99国产一区二区三区| 最近中文字幕免费mv视频7| 亚洲精品无码专区| 精品伊人久久大香线蕉网站| 国产亚洲人成网站在线观看| 亚洲五月综合缴情婷婷| 天堂а√在线最新版在线8| 中国体育生gary飞机| 日本黄色激情片| 亚洲国产成+人+综合| 激情五月婷婷色| 制服丝袜自拍偷拍| 色依依视频视频在线观看| 国产女人视频免费观看| 二个人看的www免费视频| 在线播放无码高潮的视频| 一区二区三区四区在线播放 | 色偷偷成人网免费视频男人的天堂 | 精品欧美一区二区精品久久| 国产免费拔擦拔擦8x高清在线人|